Endocannabinoid/Endocannabinoid-like
Endocannabinoid/Endocannabinoid-like(内源性大麻素/类内源性大麻素)
Endocannabinoid/Endocannabinoid-like 相关产品(139)
- GC18506N-Arachidonoyl DopamineCAS: 199875-69-9纯度: >98.50%
An arachidonoyl amino acid and CB 1 receptor agonist
- GC30815Synaptamide (Dehydroepiandrosteron(DHEA))CAS: 162758-94-3纯度: >98.00%
Synaptamide (Dehydroepiandrosteron(DHEA))是一种内源性GPR110（ADGRF1）配体，可刺激cAMP生成，EC 50 值为1.27nM。
- GC40408Glycerophospho-N-Palmitoyl EthanolamineCAS: 100575-09-5纯度: >98.00%
Precursor for palmitoyl ethanolamide
- GC40691Docosanoyl EthanolamideCAS: 94109-05-4纯度: >98.00%
A saturated N-acylethanolamide for cannabinoid research
- GC41361N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamideCAS: 1258011-97-0纯度: >97.00%
A modulator of the CB 1 receptor and PPARα
- GC41487Heptadecanoyl EthanolamideCAS: 53832-59-0纯度: >98.00%
A synthetic analog of palmitoyl ethanolamide
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC17636 | Noladin ether | 222723-55-9 | - | |
A potent and selective agonist of the CB 1 receptor and GPR55 | ||||
| GC18506 | N-Arachidonoyl Dopamine | 199875-69-9 | >98.50% | |
An arachidonoyl amino acid and CB 1 receptor agonist | ||||
| GC18719 | Docosatetraenoyl Ethanolamide | 150314-35-5 | >98.00% | |
An endocannabinoid | ||||
| GC18738 | Prostaglandin E1 Ethanolamide | 210976-81-1 | - | |
The ethanolamine-amide analog of PGE 1 | ||||
| GC18874 | Prostaglandin F2α serinol amide | 1135226-99-1 | - | |
A stable analog of PGF 2α 2glyceryl ester | ||||
| GC19446 | trans-4,5-epoxy-2(E)-Decenal | 134454-31-2 | >95.00% | |
A lipid peroxidation by-product | ||||
| GC30815 | Synaptamide (Dehydroepiandrosteron(DHEA)) | 162758-94-3 | >98.00% | |
Synaptamide (Dehydroepiandrosteron(DHEA))是一种内源性GPR110（ADGRF1）配体，可刺激cAMP生成，EC 50 值为1.27nM。 | ||||
| GC40297 | R-2 Methanandamide | 157182-47-3 | >98.00% | |
A cannabinoid analog | ||||
| GC40400 | 2-Linoleoyl Glycerol | 3443-82-1 | >95.00% | |
A congener of 2-arachidonoyl glycerol | ||||
| GC40405 | 2-O-Hexadecyl Glycerol | 1931-78-8 | >95.00% | |
A monoglycerolipid | ||||
| GC40408 | Glycerophospho-N-Palmitoyl Ethanolamine | 100575-09-5 | >98.00% | |
Precursor for palmitoyl ethanolamide | ||||
| GC40469 | 1-Arachidonoyl Glycerol | 35474-99-8 | >95.00% | |
An endogenous CB receptor ligand | ||||
| GC40687 | Docosaenoyl Ethanolamide | 18190-74-4 | >98.00% | |
An endocannabinoid | ||||
| GC40691 | Docosanoyl Ethanolamide | 94109-05-4 | >98.00% | |
A saturated N-acylethanolamide for cannabinoid research | ||||
| GC40817 | γ-Linolenoyl Ethanolamide | 150314-37-7 | >95.00% | |
An endocannabinoid | ||||
| GC40821 | CAY10435 | 288862-73-7 | >98.00% | |
A potent, selective FAAH inhibitor | ||||
| GC40864 | JP104 | 887264-45-1 | >98.00% | |
An irreversible FAAH inhibitor | ||||
| GC40955 | PHOP | 288862-83-9 | >98.00% | |
An exceptionally potent FAAH inhibitor | ||||
| GC41185 | MAGL Inhibitor Compound 23 | 2324160-91-8 | >95.00% | |
An inhibitor of MAGL | ||||
| GC41257 | Palmitoleoyl Ethanolamide | 94421-67-7 | >98.00% | |
An N-acylethanolamine signaling molecule | ||||
| GC41288 | (±)17(18)-EpETE-Ethanolamide | 2123491-23-4 | >98.00% | |
An ω-3 endocannabinoid epoxide | ||||
| GC41361 | N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide | 1258011-97-0 | >97.00% | |
A modulator of the CB 1 receptor and PPARα | ||||
| GC41487 | Heptadecanoyl Ethanolamide | 53832-59-0 | >98.00% | |
A synthetic analog of palmitoyl ethanolamide | ||||
| GC41599 | URB754 | 86672-58-4 | >98.00% | |
A MAGL inhibitor | ||||